Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 13, 2018

SELL
$35.34 - $41.9 $1.12 Million - $1.32 Million
-31,568 Closed
0 $0
Q3 2017

Nov 07, 2017

SELL
$39.44 - $41.55 $84,243 - $88,750
-2,136 Reduced 6.34%
31,568 $1.28 Million
Q2 2017

Aug 14, 2017

BUY
N/A
33,704
33,704 $1.45 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Ashfield Capital Partners, LLC Portfolio

Follow Ashfield Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.